Two Harbors Reports $222M Loss in Q2

July 29, 2025

Read More →

Procaccianti Hotel REIT Approves $2.39M in Distributions

July 29, 2025

Read More →

Foundations Investment Advisors Reveals 5.5% Ownership in First Trust ETF

July 29, 2025

Read More →

Targa Resources Extends $600 Million Receivables Facility Through August 2026

July 29, 2025

Read More →

VineBrook Calls Off Shareholder Meeting Due to Lack of Quorum

July 28, 2025

Shareholder Meeting Canceled After Low Turnout


VineBrook Homes Trust, Inc. has called off its 2025 Annual Meeting of Stockholders after falling short of the required quorum—only 26.57% of eligible shares were represented. The meeting had already been pushed once, from June 10 to July 28, but without enough proxy votes in hand, the company opted to cancel.



Before the cancellation, early results were in. Shareholders who did vote showed broad support for the seven director nominees and for the ratification of KPMG LLP as the 2025 auditor. But with more than 73% of shares unrepresented, the company withdrew all proposals and ended the process.

Read More →

Sign Up for our newsletter to get daily news and insights on alts!


Prospect Fund Extends Fee Waiver

July 28, 2025

The fund locks in zero advisory fees through 2026 while maintaining a 10% annualized yield target.

Read More →

Latest in the News

American Strategic Investment Co. Sets Date for Q2 Earnings Release

The firm will also host a live webcast to discuss performance and outlook amid market uncertainty.

Read More →

Eagle Point Trims Stake in ACRES Commercial Realty Preferred Shares

Despite the sale, the investment firm retains substantial holdings across ACRES’ common and preferred equity classes.

Read More →

CNL Strategic Capital Increases NAV

Valuations rose for most portfolio holdings in June, supporting new public offering prices and steady payouts.

Read More →

Phillips Edison Lifts Full-Year Outlook

Robust leasing activity, rising occupancy, and over $287 million in acquisitions anchor PECO’s momentum.

Read More →

Vir Biotechnology Doses First Patient in Early Trial of Cancer Therapy

July 25, 2025

The novel dual-masked T-cell engager aims to improve safety and efficacy in treating aggressive solid tumors.

Read More →

Lightstone Sells Bronx Development Site

July 25, 2025

The transaction clears $40 million in mortgage debt and includes nonrefundable extensions from buyers.

Read More →